Anteris Technologies Global Corp. AVR

FY2025 · ended Dec 31, 2025 · Revenue $1.91M · Filed Feb 26, 2026

Anteris Technologies Global Corp. (AVR) files with the SEC under industry code 3842, Orthopedic, Prosthetic & Surgical Appliances & Supplies. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $1.9 million and a net loss of $94.1 million. Free cash flow was -$79.8 million. As of Jun 30, 2026 it held $249.9 million in cash and investments and $2.9 million in total debt.

Revenue (TTM)
$2.24M
Net income (TTM)
$-103.56M
Operating cash flow (TTM)
$-86.26M
Free cash flow (TTM)
$-88.21M
EPS (TTM)
$-1.63
Dividend per share
None
Shares outstanding
97.23M
+169.6% vs prior year
Net cash
$246.99M
as of Jun 30, 2026
Operating margin
-4738.4%
FY 2026

Company profile

Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842)
Listed as
AVR (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Eagan, MN
SEC filer status
, Emerging growth company
SEC CIK
2011514

Other Orthopedic, Prosthetic & Surgical Appliances & Supplies companies

Key figures

Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.

Line
FY 2025
Dec 31, 2025
Revenue
$1.9M
Operating income
-$93.9M
Net income
-$94.1M
Diluted EPS
-$2.55
Operating cash flow
-$77.8M
Free cash flow
-$79.8M
Total assets
$23.0M
Total liabilities
$23.2M
Stockholders' equity
-$93,000
Cash and investments
$12.6M
Total debt
$2.3M

Recent SEC filings

Recent SEC filings
Form Description Filed Period
8-K Current report
Material agreement
Sep 23, 2026 Sep 23, 2026
8-K Current report
Officer or director change
Sep 17, 2026 Sep 12, 2026
8-K Current report
Officer or director change
Sep 8, 2026 Sep 4, 2026
8-K Current report
Results of operations
Aug 12, 2026 Aug 11, 2026
10-Q Quarterly report Aug 11, 2026 Jun 30, 2026
8-K Current report
Regulation FD disclosure
Aug 3, 2026 Aug 3, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.